全球巴比妥类药物市场规模、份额、趋势和成长分析报告（2026-2034年）

巴比妥酸盐药市场预计将从 2025 年的 5.2844 亿美元成长到 2034 年的 7.1335 亿美元，2026 年至 2034 年的复合年增长率为 3.39%。

由于巴比妥酸盐药在特定神经系统疾病和麻醉应用中的持续医疗用途，全球巴比妥酸盐药市场保持稳定需求。巴比妥酸盐药是中枢神经系统抑制剂，主要用于治疗严重失眠和阵发性睡眠障碍，以及作为医疗手术中的麻醉剂。在专业医疗环境中，对其使用进行严格控制仍然至关重要。

多种因素影响巴比妥类药物市场。药物研究的进步加深了我们对神经系统疾病和治疗方案的理解。在某些情况下，当其他药物不适用时，巴比妥酸盐药仍可用于治疗某些疾病。由于这些药物具有强大的药理作用，医疗专业人员会谨慎地管理其使用。

预计未来巴比妥酸盐药市场将保持稳定，这主要得益于临床实践中对其使用的严格控制。神经学研究有望改进治疗方法并开发出更安全的製剂。儘管新型药物将广泛应用，但巴比妥酸盐药仍将在特定医疗治疗中发挥重要作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球巴比妥类药物市场：依药物类型划分

• 市场分析、洞察与预测
• 长效型巴比妥酸盐药
• 短效型巴比妥酸盐药
• 超短效巴比妥酸盐药
• 组合药物

第五章：全球巴比妥类药物市场：依应用领域划分

• 市场分析、洞察与预测
• 失眠
• 癫痫
• 镇静
• 其他用途

第六章：全球巴比妥类药物市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第七章 全球巴比妥类药物市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • AbbVie Inc
  • Akorn Inc
  • Centurion Healthcare Private Limited
  • Ethypharm
  • GSK Plc
  • Intas Pharmaceuticals Ltd
  • Johnson & Johnson
  • Merck & Co. Inc
  • Novartis AG
  • Par Pharmaceutical Companies Inc
  • Pfizer Inc

The Barbiturate Drugs Market size is expected to reach USD 713.35 Million in 2034 from USD 528.44 Million (2025) growing at a CAGR of 3.39% during 2026-2034.

The global barbiturate drugs market has maintained steady demand due to the continued medical use of barbiturates in certain neurological and anesthetic applications. Barbiturates are central nervous system depressants that are primarily used for treating severe insomnia, seizure disorders, and as anesthetic agents in medical procedures. Their controlled use remains important in specialized medical settings.

Several factors are influencing the barbiturate drugs market. Advances in pharmaceutical research have improved understanding of neurological disorders and treatment options. In some cases, barbiturates remain valuable for managing specific medical conditions where alternative medications may not be suitable. Healthcare providers carefully regulate the use of these drugs due to their strong pharmacological effects.

In the future, the barbiturate drugs market is expected to remain stable with controlled medical usage. Research in neurological medicine may lead to improved treatment approaches and safer formulations. While newer drug classes are widely used, barbiturates will continue to serve specialized roles in certain medical treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Type

• Long-Acting Barbiturate
• Short-Acting Barbiturate
• Ultra-Short Acting Barbiturate
• Combination Drugs

By Application

• Insomnia
• Epilepsy
• Sedation
• Other Applications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Abbott Laboratories, AbbVie Inc, Akorn Inc, Centurion Healthcare Private Limited, Ethypharm, GSK plc, Intas Pharmaceuticals Ltd, Johnson Johnson, Merck Co Inc, Novartis AG, Par Pharmaceutical Companies Inc, Pfizer Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BARBITURATE DRUGS MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Type
• 4.2. Long-Acting Barbiturate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Short-Acting Barbiturate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ultra-Short Acting Barbiturate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Combination Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BARBITURATE DRUGS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Insomnia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sedation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BARBITURATE DRUGS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BARBITURATE DRUGS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BARBITURATE DRUGS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 AbbVie Inc
  • 9.2.3 Akorn Inc
  • 9.2.4 Centurion Healthcare Private Limited
  • 9.2.5 Ethypharm
  • 9.2.6 GSK Plc
  • 9.2.7 Intas Pharmaceuticals Ltd
  • 9.2.8 Johnson & Johnson
  • 9.2.9 Merck & Co. Inc
  • 9.2.10 Novartis AG
  • 9.2.11 Par Pharmaceutical Companies Inc
  • 9.2.12 Pfizer Inc